ABMD - アビオメド (ABIOMED Inc.)

ABMDのニュース

   Global Ventricular Assist Devices Market 2020-2024 | Evolving Opportunities with Abbott Laboratories and Abiomed Inc. | Technavio  2020/03/27 14:00:00 Business Wire
LONDON--(BUSINESS WIRE)-- #GlobalVentricularAssistDevicesMarket--The global ventricular assist devices (VAD) market has the potential to grow by USD 943.27 million during 2020-2024
   Abiomed announces measures amid COVID-19 pandemic  2020/03/25 12:20:37 Seeking Alpha
Abiomed (NASDAQ:ABMD) takes following steps during the COVID-19 outbreak. The company is adopting a work-from-home policy for all employees worldwide who a
   Abiomed’s Response to the COVID-19 Pandemic  2020/03/25 11:05:00 Business Wire
DANVERS, Mass.--(BUSINESS WIRE)--Abiomed (NASDAQ: ABMD), maker of the Impella heart pump, is taking a number of steps to aid the global medical community and contribute to improved patient care during the COVID-19 outbreak. Impella heart pumps are FDA approved to provide circulatory support to allow the heart to rest and recover for patients suffering from cardiogenic shock, including AMI, right heart failure, cardiomyopathy and myocarditis, or for patients with advanced heart failure undergoin
   The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings  2020/03/13 11:52:53 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) Masimo Corporation (NASDAQ: MASI ) Down In The Dumps (Biotech stocks that hit 52-week lows March 12.) Abbott Laboratories (NYSE: ABT ) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Aileron Therapeutics Inc (NASDAQ: ALRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Akari Therapeutics PLC (NASDAQ: AKTX ) Akcea Therapeutics Inc (NASDAQ: AKCA ) Akero Therapeutics Inc (NASDAQ: AKRO ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc.
   The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index  2020/03/10 13:19:55 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Enzo Biochem, Inc. (NYSE: ENZ ) Centogene NV (NASDAQ: CNTG ) Inovio Pharmaceuticals Inc (NASDAQ: INO ) Spherix Inc (NASDAQ: SPEX ) ( added to Friday's advance on clinching an option agreement for coronavirus treatment) Down In The Dumps (Biotech stocks that hit 52-week lows March 9.) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc. (NASDAQ: AKRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alexion Pharmaceuticals, Inc.
   The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy  2020/02/27 12:35:07 Benzinga
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Feb. 26.) Co-Diagnostics Inc (NASDAQ: CODX ) Fate Therapeutics Inc (NASDAQ: FATE ) Gilead Sciences, Inc. (NASDAQ: GILD ) Inspire Medical Systems Inc (NYSE: INSP ) (reacted to fourth-quarter results) Mersana Therapeutics Inc (NASDAQ: MRSN ) Moderna Inc (NASDAQ: MRNA ) Nevro Corp (NYSE: NVRO ) (announced fourth-quarter results) Oyster Point Pharma Inc (NASDAQ: OYST ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Revolution Medicines Inc (NASDAQ: RVMD ) Vir Biotechnology Inc (NASDAQ: VIR ) (announced a collaboration with WuXi Biologics for the development of antibodies to treat COVID-19) Down In The Dumps (Biotech stocks that hit 52-week lows Feb. 26.) ABIOMED, Inc. (NASDAQ: ABMD ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Acorda Therapeutics Inc (NASDAQ: ACOR ) AngioDynamics, Inc. (NASDAQ: ANGO ) ANCHIANO THERAP/S ADR (NASDAQ: ANCN ) Aptevo Therapeutics Inc (NASDAQ: APVO ) Auris Medical Holding Ltd (NASDAQ: EARS )(announced publication of results of a study showing anti-epileptic and anti-convulsive activity of betahistine in a mouse model) Blueprint Medicines Corp (NASDAQ: BPMC ) Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX ) Curis, Inc. (NASDAQ: CRIS ) Enochian Biosciences Inc (NASDAQ: ENOB ) Galectin Therapeutics Inc.
   Abiomed (ABMD): A look at what lies ahead for this medical device company  2020/02/12 19:54:51 news.alphastreet.com
Shares of Abiomed Inc. (NASDAQ: ABMD) were down 4% in afternoon trade on Wednesday. The stock has dropped 22% over the past three months and…
   ABIOMED (ABMD) Earnings Beat Estimates in Q3, Revenues Miss  2020/02/06 08:23:00 Zacks Investment Research
Flagship Impella drives ABIOMED's (ABMD) fiscal third-quarter results; FY20 revenue guidance slashed.
   ABIOMED (ABMD) Announces Preliminary Q3 Results, Slashes View  2020/01/14 06:22:00 Zacks Investment Research
ABIOMED's (ABMD) Q3 international revenues grew year over year; fiscal 2020 view slashed.
   10 Worst Performing S&P 500 Stocks Of 2019  2019/12/24 16:18:36 Benzinga Feeds
The S&P 500 had another big year this year, gaining more than 28% year to date. Most U.S. investors had a lot of winners in their portfolios this year, but not all companies were along for the bull market ride. Here’s a look at the 10 worst-performing stocks in the entire S&P 500 in 2019, as of the Dec. 20 closing price. 1. Fossil Group Inc (NASDAQ: FOSL ) Fossil investors have been on a rollercoaster ride in the past few years, and 2019 was mostly a free-fall, with the watchmaker’s stock dropping 51.1%. 2. ABIOMED, Inc. (NASDAQ: ABMD ) An FDA letter about the safety of ABIOMED’s Impella RP device wasn’t enough to eliminate market skepticism in 2019, and ABIOMED shares tumbled 49.8%. 3. Macy's Inc (NYSE: M ) Investors seem to be increasingly concerned that Macy’s is heading down the same long-term path as Sears Holdings … Full story available on Benzinga.com
   ABIOMED (ABMD) Announces Preliminary Q3 Results, Slashes View  2020/01/14 06:22:00 Zacks Investment Research
ABIOMED's (ABMD) Q3 international revenues grew year over year; fiscal 2020 view slashed.
   10 Worst Performing S&P 500 Stocks Of 2019  2019/12/24 16:18:36 Benzinga Feeds
The S&P 500 had another big year this year, gaining more than 28% year to date. Most U.S. investors had a lot of winners in their portfolios this year, but not all companies were along for the bull market ride. Here’s a look at the 10 worst-performing stocks in the entire S&P 500 in 2019, as of the Dec. 20 closing price. 1. Fossil Group Inc (NASDAQ: FOSL ) Fossil investors have been on a rollercoaster ride in the past few years, and 2019 was mostly a free-fall, with the watchmaker’s stock dropping 51.1%. 2. ABIOMED, Inc. (NASDAQ: ABMD ) An FDA letter about the safety of ABIOMED’s Impella RP device wasn’t enough to eliminate market skepticism in 2019, and ABIOMED shares tumbled 49.8%. 3. Macy's Inc (NYSE: M ) Investors seem to be increasingly concerned that Macy’s is heading down the same long-term path as Sears Holdings … Full story available on Benzinga.com
   Global Ventricular Assist Devices Market 2020-2024 | Evolving Opportunities with Abiomed Inc. and CorWave SA | Technavio  2019/12/03 14:00:00 Business Wire
LONDON--(BUSINESS WIRE)-- #Healthcare--Global ventricular assist devices market is poised to grow by USD 943.27 million during 2020-2024 at a CAGR of almost 12% during the forecast period.
   Abiomed Medical Office Completes Review of Observational Analysis of Impella Presented at AHA  2019/11/19 18:11:00 Benzinga Feeds
Abiomed (NASDAQ: ABMD ) is committed to improving patient outcomes by performing FDA studies and post-market surveillance, collecting real-world evidence and identifying and sharing best practices. Impella is the most studied mechanical circulatory support device in the history of the FDA with real-world clinical data on more than 110,000 patients in the Impella Quality (IQ) Database, FDA randomized controlled trials (RCT) and post-approval studies with greater than 5,000 patients, and more than 550 peer-reviewed publications. Impella is proven to provide superior hemodynamic support over the intra-aortic balloon pump (IABP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191119005932/en/ Figure 1: Clinical Variables Poorly Matched in Amin, et al. (Graphic: Business Wire) Today the Abiomed medical office is issuing a publication review of the observational analysis of Impella that was presented by Amin et al. at the American Heart Association Conference (AHA) on November 17.
   Abiomed (ABMD) Earnings Expected to Grow: Should You Buy?  2019/10/24 14:32:25 Zacks Investment Research
Abiomed (ABMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

calendar